| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate |
2020-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed3d178ae5972ed2a61064bab4fec0fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92c72d6dcf818e70026f4c1b5f15118f |
| publicationDate |
2021-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102242639-B1 |
| titleOfInvention |
Biomaker miRNA4668-5p for diagnosing liver fibrosis |
| abstract |
The present invention can replace liver biopsy by providing miRNA 4668-5p as a biomarker for liver fibrosis diagnosis, and in particular, early treatment through early diagnosis of advanced fibrosis showing a poor prognosis in non-alcoholic fatty liver patients is possible. do. In addition, the present invention makes it possible to prevent or treat liver fibrosis by regulating the expression level of miRNA 4668-5p, and is expected to create high added value by providing a method for developing liver fibrosis drugs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114452294-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230130433-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230130432-A |
| priorityDate |
2020-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |